In particular, we have previously shown that CD4+ CAR T cells are poorly effective in a model of Myc-driven B-cell lymphoma (Eμ-myc), whereas CD8+ CAR T cells (CAR8 T cells) readily induced tumor regression15,42. This evidence concerns the gene CD8A and B-cell non-Hodgkin lymphoma.